Lista de obras - Jerzy Windyga - Dominio Público Uruguay

A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A

scientific article published on 30 September 2018

A rare case of bilateral renal artery thrombosis in a patient with atrial fibrillation despite appropriate anticoagulation

artículo científico publicado en 2016

Acquired hemophilia: a case report

artículo científico publicado en 2008

Activated prothrombin complex concentrate in combination with tranexamic acid: a single centre experience for the treatment of mucosal bleeding and dental extraction in haemophilia patients with inhibitors

artículo científico publicado en 2016

Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans

artículo científico publicado en 2014

An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies ⬇️

artículo científico publicado el 1 de marzo de 2011

Angiodysplasia as a cause of recurrent bleeding from the small bowel in patients with von Willebrand disease. Report of 4 patients

scientific article published on 01 January 2004

Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors

artículo científico publicado en 2011

BAX326 (RIXUBIS): a novel recombinant factor IX for the control and prevention of bleeding episodes in adults and children with hemophilia B

artículo científico publicado en 2014

BAX326 (recombinant coagulation factor IX) for the treatment and prophylaxis of hemophilia B.

artículo científico publicado en 2014

BAY 81-8973, a full-length recombinant factor VIII for the treatment of hemophilia A: product review

artículo científico publicado en 2018

Blood pressure profile, sympathetic nervous system activity and subclinical target organ damage in patients with polycythemia vera

artículo científico publicado en 2020

Catastrophic antiphospholipid syndrome

artículo científico publicado en 2009

Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity

artículo científico publicado en 2015

Clinical efficacy of a novel VWF-containing FVIII concentrate, Wilate(®), in the prophylaxis and treatment of bleeding episodes in previously treated haemophilia A patients

artículo científico publicado en 2011

Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data

scientific article published on 08 November 2018

Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS.

artículo científico publicado en 2013

Determination and interpretation of MTHFR gene mutations in gynecology and internal medicine

scientific article published on 30 October 2019

Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients.

artículo científico publicado en 2012

EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks

artículo científico publicado en 2019

Efficacy and safety of a recombinant factor IX (Bax326) in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open-label, uncontrolled, multicentre, phase III s

artículo científico publicado en 2014

Efficacy and safety of prophylaxis with once-weekly BAY 79–4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients

artículo científico publicado en 2012

Emicizumab Prophylaxis in Hemophilia A with Inhibitors

artículo científico publicado en 2017

Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke.

artículo científico publicado en 2001

Fostamatinib for the Treatment of Adult Persistent and Chronic Immune Thrombocytopenia: Results of Two Phase 3, Randomized, Placebo-Controlled Trials.

artículo científico publicado en 2018

Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report

artículo científico publicado en 2019

Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 (COVID-19) pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society

artículo científico publicado en 2020

Guidelines for the prevention and treatment of venous thromboembolism in non-surgically treated cancer patients

artículo científico publicado en 2016

Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease

artículo científico publicado en 2015

Heyde's syndrome without a decrease in large von Willebrand factor multimers: a case of intestinal bleedings reversed by valve replacement in a patient with aortic stenosis.

artículo científico publicado en 2009

Individual thrombin generation and spontaneous bleeding rate during personalized prophylaxis with Nuwiq® (human-cl rhFVIII) in previously treated patients with severe haemophilia A

artículo científico publicado en 2018

Inhibitor development in haemophilia according to concentrate

artículo científico publicado en 2015

Inhibitor development in non-severe haemophilia across Europe.

artículo científico publicado en 2015

Is Continuous Low-Dose Prophylaxis Superior to On-Demand Treatment for Patients with Hemophilia?

artículo científico publicado en 2016

Management of bleeding or urgent interventions in patients treated with direct oral anticoagulants: 2017 recommendations for Poland

artículo científico publicado en 2017

Managing Haemophilia for Life: 5th Haemophilia Global Summit

artículo científico publicado en 2015

Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary intervention.

artículo científico publicado en 2016

Orthopedic procedures in patients with congenital coagulation disorders: single center experience

artículo científico publicado en 2013

PK-guided personalized prophylaxis with Nuwiq(®) (human-cl rhFVIII) in adults with severe haemophilia A.

artículo científico publicado en 2017

Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B

artículo científico publicado en 2020

Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria

scientific article published on 01 June 2020

Polymorphisms in the factor VII gene and ischemic stroke in young adults

artículo científico publicado en 2010

Practical aspects of new oral anticoagulant use in atrial fibrillation

artículo científico publicado en 2014

Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.

artículo científico publicado en 2005

Puzzling outcome of the nationwide genetic survey of severe/moderate female haemophilia B in Poland

artículo científico publicado en 2019

Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura

artículo científico publicado en 2017

Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial

artículo científico publicado en 2012

Recommendations for the management of trauma or surgery-related massive blood loss.

artículo científico publicado en 2011

Reduced left ventricular strain is related to blood parameters in patients with polycythemia vera.

artículo científico publicado en 2016

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

artículo científico publicado en 2012

Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: Results from the phase 3 PROPEL study

artículo científico publicado en 2020

Safety and efficacy of BAY 81-8973 for surgery in previously treated patients with haemophilia A: results of the LEOPOLD clinical trial programme

artículo científico publicado en 2016

Safety, Immunogenicity, and Hemostatic Efficacy of Nonacog Gamma in Patients With Severe or Moderately Severe Hemophilia B: A Continuation Study

scientific article published on 01 January 2020

Severe bleeding due to hypersensitivity to vitamin K antagonist caused by the c.109G>A (p.Ala37Thr) mutation in the F9 gene in a patient with mechanical heart valve prosthesis

artículo científico publicado en 2018

Short and long-term management of haemophilia A patient requiring heart valve surgery

artículo científico publicado en 2012

Six molecular patterns leading to hemophilia A phenotype in 18 females from Poland

artículo científico publicado en 2020

Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates.

artículo científico publicado en 2014

The European Haemophilia Network (EUHANET)

artículo científico publicado en 2014

The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study

scientific article published on 14 November 2018

The first case of combined coagulation factor V and coagulation factor VIII deficiency in Poland due to a novel p.Tyr135Asn missense mutation in the MCFD2 gene.

artículo científico publicado en 2008

Therapeutic properties and safety of recombinant factor VIII and factor IX

artículo científico publicado en 2009

Total elbow arthroplasty in patient with severe von Willebrand disease

artículo científico publicado en 2014

Treatment for preventing bleeding in people with congenital bleeding disorders undergoing surgery

artículo científico publicado en 2012

Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery

artículo científico publicado en 2015

Treatment guidelines for acquired hemophilia A

artículo científico publicado en 2019

Use of objective efficacy criteria for evaluation of von Willebrand factor/factor VIII concentrates.

artículo científico publicado en 2012

WFH Guidelines for the Management of Hemophilia, 3rd edition

artículo científico publicado en 2020

World Thrombosis Day 2018 in Poland

artículo científico publicado en 2019

Wykrywanie mutacji inwersyjnych (INV22 oraz INV1) w genie F8 metodą IS-PCR u polskich chorych na ciężką hemofilię A

artículo científico publicado en 2015

Zakrzepowa plamica małopłytkowa u 3-letniego chłopca – opis przypadku

artículo científico publicado en 2012

[Acquired haemophilia].

artículo científico publicado en 2007

[Antiphospholipid antibodies as risk factor for venous thromboembolism]

scientific article published on 01 November 2002

[Application of mPCR and MLPA in diagnostics of alpha-thalassaemia].

artículo científico publicado en 2010

[GBV-C/HGV and TTV infection markers in Polish blood donors and haemophilia patients]

artículo científico publicado en 2006

[Hemophilia and other inherited blood coagulation disorders in Poland]

artículo científico publicado en 2004

[New oral anticoagulants in the prevention of embolic complications in patients with atrial fibrillation. Polish Cardiac Society, Polish Neurological Society and Working Group on Haemostasis of the Polish Society of Haematologists and Transfusiologi

artículo científico publicado en 2012

[Prevalence of HCV, HBV and HIV infections among severe Polish haemophiliacs]

artículo científico publicado en 2008

[Strategy for secure hemostasis in hemophilia patients undergoing surgery for malignant neoplasms]

artículo científico publicado en 2009

[The orthopaedic status of a selected severe haemophilia group]

scientific article published on 01 June 2005

[Von Willebrand disease in women with menorrhagia]

scientific article published on 01 January 2004

Łagodna hiperhomocysteinemia u chorych z nadpłytkowością samoistną (NS), związek z mutacją genu MTHFR i poziomem kwasu foliowego

artículo científico publicado en 2013

Lista de obras de Jerzy Windyga

A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A

A rare case of bilateral renal artery thrombosis in a patient with atrial fibrillation despite appropriate anticoagulation

Acquired hemophilia: a case report

Activated prothrombin complex concentrate in combination with tranexamic acid: a single centre experience for the treatment of mucosal bleeding and dental extraction in haemophilia patients with inhibitors

Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans

An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies ⬇️

Angiodysplasia as a cause of recurrent bleeding from the small bowel in patients with von Willebrand disease. Report of 4 patients

Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors

BAX326 (RIXUBIS): a novel recombinant factor IX for the control and prevention of bleeding episodes in adults and children with hemophilia B

BAX326 (recombinant coagulation factor IX) for the treatment and prophylaxis of hemophilia B.

BAY 81-8973, a full-length recombinant factor VIII for the treatment of hemophilia A: product review

Blood pressure profile, sympathetic nervous system activity and subclinical target organ damage in patients with polycythemia vera

Catastrophic antiphospholipid syndrome

Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity

Clinical efficacy of a novel VWF-containing FVIII concentrate, Wilate(®), in the prophylaxis and treatment of bleeding episodes in previously treated haemophilia A patients

Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data

Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS.

Determination and interpretation of MTHFR gene mutations in gynecology and internal medicine

Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients.

EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks

Efficacy and safety of a recombinant factor IX (Bax326) in previously treated patients with severe or moderately severe haemophilia B undergoing surgical or other invasive procedures: a prospective, open-label, uncontrolled, multicentre, phase III s

Efficacy and safety of prophylaxis with once-weekly BAY 79–4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients

Emicizumab Prophylaxis in Hemophilia A with Inhibitors

Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke.

Fostamatinib for the Treatment of Adult Persistent and Chronic Immune Thrombocytopenia: Results of Two Phase 3, Randomized, Placebo-Controlled Trials.

Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report

Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 (COVID-19) pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society

Guidelines for the prevention and treatment of venous thromboembolism in non-surgically treated cancer patients

Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease

Heyde's syndrome without a decrease in large von Willebrand factor multimers: a case of intestinal bleedings reversed by valve replacement in a patient with aortic stenosis.

Individual thrombin generation and spontaneous bleeding rate during personalized prophylaxis with Nuwiq® (human-cl rhFVIII) in previously treated patients with severe haemophilia A

Inhibitor development in haemophilia according to concentrate

Inhibitor development in non-severe haemophilia across Europe.

Is Continuous Low-Dose Prophylaxis Superior to On-Demand Treatment for Patients with Hemophilia?

Management of bleeding or urgent interventions in patients treated with direct oral anticoagulants: 2017 recommendations for Poland

Managing Haemophilia for Life: 5th Haemophilia Global Summit

Meta-analysis of uninterrupted as compared to interrupted oral anticoagulation with or without bridging in patients undergoing coronary angiography with or without percutaneous coronary intervention.

Orthopedic procedures in patients with congenital coagulation disorders: single center experience

PK-guided personalized prophylaxis with Nuwiq(®) (human-cl rhFVIII) in adults with severe haemophilia A.

Phase 3 Clinical Trial: Perioperative Use of Nonacog Gamma, a Recombinant Factor IX, in Previously Treated Patients With Moderate/Severe Hemophilia B

Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria

Polymorphisms in the factor VII gene and ischemic stroke in young adults

Practical aspects of new oral anticoagulant use in atrial fibrillation

Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.

Puzzling outcome of the nationwide genetic survey of severe/moderate female haemophilia B in Poland

Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura

Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial

Recommendations for the management of trauma or surgery-related massive blood loss.

Reduced left ventricular strain is related to blood parameters in patients with polycythemia vera.

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia

Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: Results from the phase 3 PROPEL study

Safety and efficacy of BAY 81-8973 for surgery in previously treated patients with haemophilia A: results of the LEOPOLD clinical trial programme

Safety, Immunogenicity, and Hemostatic Efficacy of Nonacog Gamma in Patients With Severe or Moderately Severe Hemophilia B: A Continuation Study

Severe bleeding due to hypersensitivity to vitamin K antagonist caused by the c.109G>A (p.Ala37Thr) mutation in the F9 gene in a patient with mechanical heart valve prosthesis

Short and long-term management of haemophilia A patient requiring heart valve surgery

Six molecular patterns leading to hemophilia A phenotype in 18 females from Poland

Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates.

The European Haemophilia Network (EUHANET)

The effect of emicizumab prophylaxis on health-related outcomes in persons with haemophilia A with inhibitors: HAVEN 1 Study

The first case of combined coagulation factor V and coagulation factor VIII deficiency in Poland due to a novel p.Tyr135Asn missense mutation in the MCFD2 gene.

Therapeutic properties and safety of recombinant factor VIII and factor IX

Total elbow arthroplasty in patient with severe von Willebrand disease

Treatment for preventing bleeding in people with congenital bleeding disorders undergoing surgery

Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery

Treatment guidelines for acquired hemophilia A

Use of objective efficacy criteria for evaluation of von Willebrand factor/factor VIII concentrates.

WFH Guidelines for the Management of Hemophilia, 3rd edition

World Thrombosis Day 2018 in Poland

Wykrywanie mutacji inwersyjnych (INV22 oraz INV1) w genie F8 metodą IS-PCR u polskich chorych na ciężką hemofilię A

Zakrzepowa plamica małopłytkowa u 3-letniego chłopca – opis przypadku

[Acquired haemophilia].

[Antiphospholipid antibodies as risk factor for venous thromboembolism]

[Application of mPCR and MLPA in diagnostics of alpha-thalassaemia].

[GBV-C/HGV and TTV infection markers in Polish blood donors and haemophilia patients]

[Hemophilia and other inherited blood coagulation disorders in Poland]

[New oral anticoagulants in the prevention of embolic complications in patients with atrial fibrillation. Polish Cardiac Society, Polish Neurological Society and Working Group on Haemostasis of the Polish Society of Haematologists and Transfusiologi

[Prevalence of HCV, HBV and HIV infections among severe Polish haemophiliacs]

[Strategy for secure hemostasis in hemophilia patients undergoing surgery for malignant neoplasms]

[The orthopaedic status of a selected severe haemophilia group]